rosiglitazone has been researched along with Schizophrenia in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Araujo de Baptista, E; Baptista, T; Beaulieu, S; El Fakih, Y; Galeazzi, T; Rangel, N; Uzcátegui, E | 1 |
| Borba, CP; Boxill, R; Cather, C; Copeland, PM; Eden Evins, A; Fan, X; Freudenreich, O; Goff, DC; Henderson, DC; Sharma, B | 1 |
| Argo, TR; Housel, AK; Waterbury, N | 1 |
| Fan, X; Freudenreich, O; Goff, D; Henderson, DC; Liu, D; Wang, J; Yi, Z | 1 |
1 review(s) available for rosiglitazone and Schizophrenia
| Article | Year |
|---|---|
Can metformin or rosiglitazone reduce metabolic side effects associated with atypical antipsychotics?
Topics: Antipsychotic Agents; Humans; Hypoglycemic Agents; Metabolic Syndrome; Metformin; Randomized Controlled Trials as Topic; Risk Factors; Rosiglitazone; Schizophrenia; Thiazolidinediones; Weight Gain | 2009 |
3 trial(s) available for rosiglitazone and Schizophrenia
| Article | Year |
|---|---|
Rosiglitazone in the assistance of metabolic control during olanzapine administration in schizophrenia: a pilot double-blind, placebo-controlled, 12-week trial.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Body Mass Index; Body Weight; Double-Blind Method; Female; Fibrinogen; Hemoglobins; Humans; Hypoglycemic Agents; Insulin Resistance; Lipid Metabolism; Male; Metabolic Diseases; Middle Aged; Olanzapine; Pilot Projects; Rosiglitazone; Schizophrenia; Statistics as Topic; Thiazolidinediones | 2009 |
A double-blind, placebo-controlled trial of rosiglitazone for clozapine-induced glucose metabolism impairment in patients with schizophrenia.
Topics: Adolescent; Adult; Aged; Blood Glucose; Cholesterol, LDL; Clozapine; Double-Blind Method; Female; Glucose Tolerance Test; Humans; Hypoglycemic Agents; Insulin Resistance; Male; Metabolic Syndrome; Middle Aged; Placebos; Rosiglitazone; Schizophrenia; Thiazolidinediones | 2009 |
Rosiglitazone and cognitive function in clozapine-treated patients with schizophrenia: a pilot study.
Topics: Adult; Antipsychotic Agents; Clozapine; Cognition; Cognition Disorders; Double-Blind Method; Female; Humans; Hypoglycemic Agents; Male; Middle Aged; Neuropsychological Tests; Pilot Projects; PPAR gamma; Rosiglitazone; Schizophrenia; Thiazolidinediones; Treatment Outcome | 2012 |